Within days, I expect to see the one analyst who follows DUSA to raise his earnings estimate for 2010 from -.06 to AT LEAST -.02.
IMO, he will still be too low.
IFFFFFF management does not do any of those stupid things of the past, 2010 should be AT LEAST +.05.
It COULD BE as high as +.10!

One key will be for DUSA to control costs of the SOTR trials OR, preferably, to get a PARTNER to sponsor those trials, imo.
However, they might not want to partner this $250 million potential new market. It will be a delicate situation to go just fast enough on the SOTR trial in order to get it done in our lifetimes vs BLOWING the company's upcoming opportunity to become profitable, stay profitable, AND MORE IMPORTANTLY, to show GROWING profits EVERY quarter vs the year before!!!!
If they can begin to do this (show growing profits every quarter)we will be looking at the extremely bullish situation of having a healthcare /drug company that is a quintessential growth company commanding a HIGH PE!!!
CROSS YOUR FINGERS that management sees the light FOR SHAREHOLDERS!!!!!